Spine FA3 - a Prospective, International, Multicenter Cohort Study on Treatment of of AO A3 Thoracolumbar Fractures

NCT ID: NCT01751633

Last Updated: 2020-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

38 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thoracolumbar fractures are the most common spinal fractures with an average annual incidence between 18 and 30 per 100'000 inhabitants. The majority of these fractures are AO type A3 ("burst fractures"). Although patients with burst fractures report a reduced quality of life and chronic pain, there is no clear evidence whether surgical or conservative treatment offer better functional and back-pain related outcomes. The indications for the selection of an ideal treatment for these fractures without neurological deficits remain controversial. The purpose of this study is to evaluate whether patients with thoracolumbar fractures without neurological deficit being surgically treated show faster recovery and better improvement of function than patients being conservatively treated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Single Level Stable Thoracolumbar Fracture Type AO A3 Multiple Level Stable Thoracolumbar Fracture Type AO A3

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical treatment

Surgical treatment according to one of the following:

* Posterior open approach
* Posterior minimally-invasive surgery (MIS) approach The choice of the approach will be left upon the surgeon's discretion

Surgical

Intervention Type PROCEDURE

Conservative treatment

Conservative treatment according to hospital's standard of care

Conservative treatment

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgical

Intervention Type PROCEDURE

Conservative treatment

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

• Posterior open approach • Posterior minimally-invasive surgery (MIS) approach Conservative treatment according to hospital's standard of care : - Bed rest followed by immobilization with: - Custom-moulded or prefabricated total body contact thoracolumbosacral orthosis (TLSO) - Thermoplastic removable brace, Jewett hyperextension braces, Anterior hyperextension brace (ASH), Taylor-Knight brace - Plaster of Paris (POP)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 years
* Diagnosis of single or multiple stable thoracolumbar fracture(s)

* Level T10- L3
* Type AO A3 or A4
* Radiologically confirmed by Rx or CT
* Fracture induced kyphotic deformity lower or equal to 20-35 degrees
* Definitive treatment (surgical or conservative) within 10 days after injury
* American Spinal Injury Association (ASIA) Impairment Scale = E (normal )
* Ability to understand patient information / informed consent form
* Willingness and ability to participate in the clinical investigation including imaging and follow-up procedures (FUs)
* Signed informed consent

Exclusion Criteria

* Open fracture
* Polytrauma
* Pathologic fracture
* Disruption of the posterior ligamentous complex between T10 and L3
* Clinically evident osteoporosis as assessed by the investigator
* Spinal luxation
* Associated severe lesions as assessed by the investigator
* Spinal lesion due to gun or projectile
* Pre-existing spinal column deformity
* Prior spinal surgeries
* BMI \> 40 kg/m2
* Any severe medically not managed systemic disease
* Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reli-able assessment
* Pregnancy or women planning to conceive within the study period
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Clinical Investigation and Publishing Documentation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giuseppe Barbagallo, MD

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliero - Universitaria Policlinico, Catania, Italy

Emiliano Vialle, MD

Role: PRINCIPAL_INVESTIGATOR

Catholic University of Parana - Curitiba, Brazil

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitaria Cajuru

Curitiba, , Brazil

Site Status

Hospital Cristo Redentor

Porto Alegre, , Brazil

Site Status

Hospital Santa Marcelina

São Paulo, , Brazil

Site Status

Hospital Cristo Redentor

Santiago, , Chile

Site Status

Krajská nemocnice Liberec

Liberec, , Czechia

Site Status

Klinikum rechts der Isar der Technischen Universität München

Munich, , Germany

Site Status

Azienda Ospedaliero - Universitaria Policlinico

Catania, , Italy

Site Status

Hospital Garcia e Orta, EPE

Almada, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil Chile Czechia Germany Italy Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Spine FA3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mangement of Spine Fracture
NCT06458309 RECRUITING NA
StUdy oN Burst Fractures (SunBurst)
NCT05003180 ACTIVE_NOT_RECRUITING NA
Spitex-SpiTal-Autonomie-Reha-Kraft
NCT03154684 TERMINATED NA